Drug stocks gain while Nanosphere sinks

Drug stocks rise while shares of Nanosphere tumble on news that U.S. regulators have refused to approve the company’s new diagnostic test.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.